H.B. Fuller (NYSE:FUL) Sets New 1-Year Low – Time to Sell?

H.B. Fuller (NYSE:FULGet Free Report) reached a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $55.38 and last traded at $55.63, with a volume of 369290 shares changing hands. The stock had previously closed at $56.74.

Wall Street Analyst Weigh In

A number of brokerages have commented on FUL. JPMorgan Chase & Co. lowered their price target on H.B. Fuller from $70.00 to $60.00 and set an “underweight” rating for the company in a research report on Friday, January 17th. Vertical Research lowered H.B. Fuller from a “buy” rating to a “hold” rating in a research report on Monday, January 6th. Deutsche Bank Aktiengesellschaft cut their price target on shares of H.B. Fuller from $75.00 to $72.00 and set a “buy” rating on the stock in a report on Wednesday, January 22nd. Finally, Citigroup decreased their price objective on shares of H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating for the company in a research note on Friday, January 3rd. One analyst has rated the stock with a sell rating, four have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, H.B. Fuller presently has an average rating of “Hold” and a consensus target price of $75.60.

Check Out Our Latest Report on FUL

H.B. Fuller Trading Down 2.0 %

The firm has a market cap of $3.04 billion, a price-to-earnings ratio of 24.08, a PEG ratio of 1.13 and a beta of 1.42. The company has a fifty day moving average price of $62.05 and a 200-day moving average price of $72.22. The company has a current ratio of 1.81, a quick ratio of 1.16 and a debt-to-equity ratio of 1.10.

H.B. Fuller (NYSE:FULGet Free Report) last released its quarterly earnings data on Wednesday, January 15th. The specialty chemicals company reported $0.92 earnings per share for the quarter, missing analysts’ consensus estimates of $1.00 by ($0.08). The firm had revenue of $923.00 million during the quarter, compared to analysts’ expectations of $916.84 million. H.B. Fuller had a net margin of 3.65% and a return on equity of 12.01%. The firm’s quarterly revenue was up 2.2% on a year-over-year basis. During the same period in the previous year, the firm posted $1.32 EPS. As a group, research analysts expect that H.B. Fuller will post 4.07 EPS for the current year.

H.B. Fuller Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, February 20th. Shareholders of record on Thursday, February 6th were given a dividend of $0.2225 per share. This represents a $0.89 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date was Thursday, February 6th. H.B. Fuller’s dividend payout ratio is presently 38.53%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Lord Abbett & CO. LLC raised its stake in H.B. Fuller by 79.8% in the 3rd quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock valued at $57,952,000 after purchasing an additional 324,056 shares during the last quarter. Bank of New York Mellon Corp lifted its stake in shares of H.B. Fuller by 17.2% in the 4th quarter. Bank of New York Mellon Corp now owns 554,947 shares of the specialty chemicals company’s stock valued at $37,448,000 after purchasing an additional 81,558 shares during the last quarter. Amundi increased its position in shares of H.B. Fuller by 191.9% during the 4th quarter. Amundi now owns 28,553 shares of the specialty chemicals company’s stock worth $1,804,000 after purchasing an additional 18,771 shares during the last quarter. Geode Capital Management LLC increased its position in shares of H.B. Fuller by 1.5% during the third quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock valued at $99,939,000 after acquiring an additional 18,734 shares during the last quarter. Finally, Kennedy Capital Management LLC lifted its holdings in shares of H.B. Fuller by 13.4% in the 4th quarter. Kennedy Capital Management LLC now owns 127,896 shares of the specialty chemicals company’s stock worth $8,630,000 after acquiring an additional 15,100 shares during the last quarter. 95.93% of the stock is owned by hedge funds and other institutional investors.

H.B. Fuller Company Profile

(Get Free Report)

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.

Featured Stories

Receive News & Ratings for H.B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H.B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.